Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Pembrolizumab monotherapy versus chemotherapy for treatment of advanced urothelial carcinoma with disease progression during or following platinum‐containing chemotherapy. A Cochrane Rapid Review

Esta versión no es la más reciente

ver la versión actual 23 julio 2018

Información

DOI:
https://doi.org/10.1002/14651858.CD012838Copiar DOI
Base de datos:
  1. Cochrane Database of Systematic Reviews
Versión publicada:
  1. 01 noviembre 2017see what's new
Tipo:
  1. Intervention
Etapa:
  1. Protocol
Grupo Editorial Cochrane:

  1. Grupo Cochrane de Urología

Copyright:
  1. Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Cifras del artículo

Altmetric:

Citado por:

Citado 0 veces por enlace Crossref Cited-by

Contraer

Autores

  • Vikram Narayan

    Department of Urology, University of Minnesota, Minneapolis, USA

  • Philipp Dahm

    Urology Section, Minneapolis VA Health Care System, Minneapolis, USA

  • Nicole Skoetz

    Cochrane Haematological Malignancies Group, Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany

  • Michael C Risk

    Urology Section, Minneapolis VA Health Care System, Minneapolis, USA

  • Connie Bongiorno

    University of Minnesota, Minneapolis, USA

  • Neil Patel

    Minneapolis VA Health Care System, Minneapolis, USA

  • Jae Hung Jung

    Department of Urology, Yonsei University Wonju College of Medicine, Wonju, Korea, South

  • Gerald Gartlehner

    Cochrane Austria, Danube University Krems, Krems, Austria

  • Frank Kunath

    Correspondencia a: Department of Urology, University Hospital Erlangen, Erlangen, Germany

    [email protected]

Contributions of authors

VK: drafted first version

PD: provided methodological oversights and reviewed final version

NK: provided methodological support and reviewed final version

MR: provided content expertise and revised/reviewed version

CB: developed search strategy

NP: provided content expertise and revised/reviewed protocol version

JHJ: provided methodological support

GG: provided methodological support and revised/reviewed final version

FK: coordinated and oversaw all aspects of the protocol development

Sources of support

Internal sources

  • University of Erlangen, Germany.

    Salary support for Frank Kunath

  • Minneapolis VAMC, Minneapolis, MN, USA.

    Salary support for Philipp Dahm

External sources

  • No sources of support supplied

Declarations of interest

VN: none

PD: none

NS: none

MR: none

CB: none

NP: none

JHJ: none

GG: none

FK: none

Acknowledgements

The authors thank the Cochrane Urology staff members for their support.

Version history

Published

Title

Stage

Authors

Version

2018 Jul 23

Pembrolizumab monotherapy versus chemotherapy for treatment of advanced urothelial carcinoma with disease progression during or following platinum‐containing chemotherapy. A Cochrane Rapid Review

Review

Vikram Narayan, Andreas Kahlmeyer, Philipp Dahm, Nicole Skoetz, Michael C Risk, Connie Bongiorno, Neil Patel, Eu Chang Hwang, Jae Hung Jung, Gerald Gartlehner, Frank Kunath

https://doi.org/10.1002/14651858.CD012838.pub2

2017 Nov 01

Pembrolizumab monotherapy versus chemotherapy for treatment of advanced urothelial carcinoma with disease progression during or following platinum‐containing chemotherapy. A Cochrane Rapid Review

Protocol

Vikram Narayan, Philipp Dahm, Nicole Skoetz, Michael C Risk, Connie Bongiorno, Neil Patel, Jae Hung Jung, Gerald Gartlehner, Frank Kunath

https://doi.org/10.1002/14651858.CD012838

Notes

Parts of the methods section are based on a standard template developed by the Cochrane Metabolic and Endocrine Disorders Group, which has been modified and adapted for use by Cochrane Urology.

Keywords

MeSH

Medical Subject Headings (MeSH) Keywords

Medical Subject Headings Check Words

Humans;

PICO

Population
Intervention
Comparison
Outcome

El uso y la enseñanza del modelo PICO están muy extendidos en el ámbito de la atención sanitaria basada en la evidencia para formular preguntas y estrategias de búsqueda y para caracterizar estudios o metanálisis clínicos. PICO son las siglas en inglés de cuatro posibles componentes de una pregunta de investigación: paciente, población o problema; intervención; comparación; desenlace (outcome).

Para saber más sobre el uso del modelo PICO, puede consultar el Manual Cochrane.